Liposomal vaccines with conformation-specific amyloid peptide antigens define immune response and efficacy in APP transgenic mice
Authors:
- 5 June 2007
- journal article
- research article
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 104 (23) , 9810-9815
Abstract
We investigated the therapeutic effects of two different versions of Aβ1–15 (16)liposome-based vaccines. Inoculation of APP-V717IxPS-1 (APPxPS-1) double-transgenic mice with tetra-palmitoylated amyloid 1–15 peptide (palmAβ1–15), or with amyloid 1–16 peptide (PEG-Aβ1–16) linked to a polyethyleneglycol spacer at each end, and embedded within a liposome membrane, elicited fast immune responses with identical binding epitopes. PalmAβ1–15liposomal vaccine elicited an immune response that restored the memory defect of the mice, whereas that of PEG-Aβ1–16had no such effect. Immunoglobulins that were generated were predominantly of the IgG class with palmAβ1–15, whereas those elicited by PEG-Aβ1–16were primarily of the IgM class. The IgG subclasses of the antibodies generated by both vaccines were mostly IgG2b indicating noninflammatory Th2 isotype. CD and NMR revealed predominantly β-sheet conformation of palmAβ1–15and random coil of PEG-Aβ1–16. We conclude that the association with liposomes induced a variation of the immunogenic structures and thereby different immunogenicities. This finding supports the hypothesis that Alzheimer's disease is a “conformational” disease, implying that antibodies against amyloid sequences in the β-sheet conformation are preferred as potential therapeutic agents.Keywords
This publication has 46 references indexed in Scilit:
- Short Amyloid-β (Aβ) Immunogens Reduce Cerebral Aβ Load and Learning Deficits in an Alzheimer's Disease Mouse Model in the Absence of an Aβ-Specific Cellular Immune ResponseThe Journal of Neuroscience, 2006
- Structural Changes of Region 1-16 of the Alzheimer Disease Amyloid β-Peptide upon Zinc Binding and in Vitro AgingJournal of Biological Chemistry, 2006
- Anti-A 42- and anti-A 40-specific mAbs attenuate amyloid deposition in an Alzheimer disease mouse modelJournal of Clinical Investigation, 2005
- An Attenuated Immune Response Is Sufficient to Enhance Cognition in an Alzheimer's Disease Mouse Model Immunized with Amyloid-β DerivativesJournal of Neuroscience, 2004
- Non-covalent stabilization of a β-hairpin peptide into liposomesOrganic & Biomolecular Chemistry, 2003
- The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to TherapeuticsScience, 2002
- Immunization reverses memory deficits without reducing brain Aβ burden in Alzheimer's disease modelNature Neuroscience, 2002
- Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic MiceScience, 1996
- Immune Response against the Murine MDRI Protein Induced by Vaccination with Synthetic Lipopeptides in LiposomesBiochemical and Biophysical Research Communications, 1995
- Physiological production of the β-amyloid protein and the mechanism of Alzheimer's diseaseTrends in Neurosciences, 1993